Led · Series B · Jul 2026

Pediatrica Health Group operates a growing network of pediatric primary care practices that deliver its Next Generation CareSM model aimed at improving outcomes for families and providers. The organization supports providers with modern technologies and resources to enable coordinated, equitable pediatric care. Pediatrica was founded through a partnership with investor M33 and has expanded to 21 locations across Florida and Texas. Its services focus on children from birth through 18 years of age and emphasize value-based care capabilities. The company plans to use recent growth capital to open more locations, hire additional providers, and invest in clinical and operational infrastructure and technology enhancements. Pediatrica's stated goal is to expand access and reduce barriers to high-quality pediatric primary care while supporting community health and provider sustainability.

Led · Series B · Dec 2025

Founded in 2021, Parallel Learning delivers psychoeducational assessments, speech-language pathology, behavioral and mental-health counseling, and specialized instruction entirely online via its Pathway platform. The system combines secure teletherapy, licensed clinicians, AI-driven personalization, and data-rich progress tracking to support understaffed school districts. During the 2024–2025 academic year, 98 % of the more than 10,000 students it serves met or exceeded their IEP goals, with particularly strong outcomes in behavioral health (94.3 % exceeding expectations). The company currently operates in 25 states, and many of its users come from communities with high Social Vulnerability Index scores. Student satisfaction is high, with Routine Outcome Monitoring scores averaging 8.9/10 for provider experience and 8.6/10 for overall well-being. Parallel plans to use new capital to scale nationwide, deepen AI integration, and broaden access across all 50 states. The firm has previously attracted investors such as Tiger Global, Vine Ventures, Obvious Ventures, and Rethink Impact.

Led · Equity · Jul 2025

Small Door Veterinary operates a membership-based veterinary care model that combines primary care, stress-free clinic environments, 24/7 telemedicine, and transparent pricing. The company emphasizes hospitality-grade service alongside clinical rigor to improve experiences for pets, pet parents, and medical teams. Small Door currently operates across the Northeast and Mid-Atlantic and is expanding nationally, recently opening practices in McLean, VA and Park Slope, Brooklyn. The company hired Kristen Lombardi as its first-ever Chief Operating Officer to support scaling operations. Small Door raised $55 million in new capital—$35M equity and a $20M debt facility—to fund growth, strategic new openings, and investments in member services, medical operations, and technology infrastructure. Management says it will continue growing in core markets while preparing for thoughtful, sustainable expansion. Small Door operates a membership-based, technology-powered veterinary care platform that combines in-person clinics with 24/7 telemedicine and modern facilities staffed by veterinarians trained at top programs. The company emphasizes personalized, high-engagement care and reports among the highest engagement rates in the industry measured by visit frequency and ARPU. Small Door currently operates five practices in New York City and has delivered tens of thousands of member consultations; its most mature units have generated healthy cash flow. It is a Certified B Corp and operates AAHA-accredited practices. The company plans to use new funding to expand beyond New York into Boston and Washington, D.C., opening five new locations in the first half of 2023. Funding will also support continued development of the Small Door platform. Small Door Veterinary is a New York–based membership veterinary care company that provides membership-based care, 24/7 telemedicine, and transparent pricing delivered with hospitality in spaces designed by animal experts. The company opened its first location in Manhattan’s West Village in early 2020 and will open a second practice on the Upper East Side in 2021. Co-founded by Josh Guttman and Florent Peyre, Small Door plans to expand its physical footprint to 25 locations by 2025. Small Door intends to use the funds from its recent raise to expand operations and its business reach. The company also announced that CityMD co-founder and Chief Growth Officer Nedal Shami has joined its board of directors. Financial operating metrics (revenue or user counts) were not disclosed in the article. Small Door operates a membership model that gives members a set number of annual check-ups, priority access to specialists, and virtual access to veterinarians based on membership tier. The company says the membership revenue model lets vets spend more time with each patient and reduces waiting-room wait times. Small Door was founded as a Public Benefit Corporation and emphasizes the wellbeing of vets and pets as key stakeholders. The startup plans to use new funding to further build out its team and product. It also intends to open its first Small Door clinic in New York City in the fall. The company has raised a seed round to support these expansion and product efforts.

Led · Series B · May 2025

Koala Health is the leading digital pet pharmacy providing seamless access to chronic pet medications through a modern, mobile-first experience. The company operates an online storefront at Koala.health that is available in all 50 states and reaches more than 80 million pet parents. For veterinarians, Koala provides a fully integrated prescription solution available to over 25,000 independent veterinary clinics, eliminating the burden of in-house medication storage and fulfillment. Koala’s platform includes one-click prescription capabilities to simplify medication management for vets and reduce delays and hassle for pet owners. With new funding, the company plans to accelerate development of its mobile-first digital experience and enhance service offerings for both pet parents and veterinarians. Koala is headquartered in Boston and is led by founder and CEO Gavin Cotter.

Led · Series A · Mar 2025

Phoenix is Canada’s leading digital health clinic for men, specializing in treatment for erectile dysfunction, weight loss, and hair loss. Its telehealth platform connects patients with licensed Canadian physicians for assessment and prescriptions and provides end-to-end fulfillment with free, discreet delivery of medications coast to coast. Phoenix is available across Ontario, Alberta, British Columbia, Saskatchewan, Manitoba, Nova Scotia, New Brunswick, PEI, and Newfoundland. The company positions itself to address gaps in access to care in Canada, noting more than 6.5 million Canadians lack a regular care provider, and focuses on lowering barriers to treatment for stigmatized conditions. With the CAD 50 million Series A, Phoenix plans to expand its team, increase brand visibility, and build infrastructure to scale operations and meet rising demand for telehealth services. Co‑founders and co‑CEOs Kevin Bache and Gavin Thompson emphasize a patient-first approach and specialized treatments as key differentiators.